Wheezing in the Elderly: Evaluation and Management
In elderly patients presenting with wheezing, initiate bronchodilator therapy with both β2-agonists and anticholinergic agents while simultaneously pursuing diagnostic evaluation to differentiate between asthma, COPD, and other serious causes including heart failure, pulmonary embolism, aspiration, and bronchogenic carcinoma.
Initial Diagnostic Approach
The evaluation must be more aggressive in elderly patients than younger populations because wheezing signals potentially life-threatening conditions beyond simple asthma 1, 2. Physical examination alone is unreliable in elderly asthmatics—they demonstrate less tachycardia and pulsus paradoxus for equivalent degrees of airway obstruction compared to younger patients, leading to underestimation of severity 3.
Essential Initial Testing:
- Chest radiography (mandatory to exclude heart failure, malignancy, aspiration)
- Spirometry with bronchodilator challenge to document reversibility
- Consider CT scanning if FEV₁ remains low after treatment to diagnose coexisting lung diseases including bronchiectasis, emphysema, or malignancy 4
- For patients >40 years with significant tobacco history and new-onset wheezing, advanced imaging is essential to evaluate for malignancy 5
Key Diagnostic Considerations:
The differential is broader than in younger patients 1:
- Asthma (can begin late in life but is uncommon)
- COPD (most common, especially with smoking history)
- Congestive heart failure (cardiac asthma)
- Pulmonary aspiration (chronic aspiration syndrome)
- Pulmonary embolism
- Bronchogenic carcinoma
When spirometry shows airflow obstruction, demonstrate reversibility to uncover an asthmatic component. If symptoms exist without obstruction, methacholine challenge testing excludes asthma and redirects evaluation toward cardiac or other causes 2.
Immediate Management
Bronchodilator Therapy
Start combination therapy immediately 6, 7:
For acute/severe presentations:
- Nebulized salbutamol 5 mg OR terbutaline 10 mg
- Add ipratropium bromide 500 μg if no improvement after initial β-agonist
- Repeat 4-6 hourly if improving
- Do NOT nebulize with oxygen in COPD patients—use 24% Venturi mask between treatments 7
For mild-moderate exacerbations:
- Inhaled β2-agonist (salbutamol 200-400 μg) OR anticholinergic (ipratropium 250-500 μg) 4-6 hourly
- Combine both classes if submaximal response 6
Critical Elderly-Specific Precautions:
- First dose supervision required 7—β-agonists may precipitate angina in elderly patients with ischemic heart disease
- Use mouthpiece rather than face mask for ipratropium to prevent acute glaucoma or blurred vision (glaucoma and prostatism are more common in elderly) 7
- Anticholinergics are more effective than β2-agonists in elderly COPD patients 6—response to β-agonists declines more rapidly with age than response to anticholinergics 7
- Avoid high-dose β-agonists unless necessary—they cause more tremor in elderly patients 7
Delivery Device Selection
Many elderly patients cannot use metered-dose inhalers effectively due to cognitive impairment, weak fingers, or poor coordination 7, 4. Consider these alternatives in order:
- Metered-dose inhaler with spacer and tight-fitting face mask
- Breath-activated inhaler
- Dry-powder inhaler
- Nebulizer (often the most practical for elderly patients) 4
Additional Acute Management
For marked wheeze, add corticosteroids from the beginning 6:
- Oral or IV corticosteroids 0.4-0.6 mg/kg daily
- Continue for 7-14 days
If sputum becomes purulent, add antibiotics empirically 6:
- Amoxicillin, tetracycline derivatives, or amoxicillin/clavulanic acid
- 7-14 day course
- Common organisms: Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis
Hospital Admission Criteria
Refer to hospital immediately if 6:
- Cannot complete sentences
- Respiratory rate >25/min
- Heart rate >110/min (though may be blunted in elderly)
- PEF <50% predicted
- Cyanosis
- Reduced activity/alertness
- PaO₂ <8.0 kPa (60 mmHg)
- PaCO₂ >6.7 kPa (50 mmHg)
Long-term Management Considerations
Elderly patients with asthma have reduced bronchodilator response and increased glucocorticoid side effects 4. Those requiring maintenance oral corticosteroids are less likely to reach predicted PEFR than younger patients 3.
Common Pitfalls:
- Relying on physical examination alone (underestimates severity in elderly)
- Assuming all wheezing is asthma or COPD without excluding malignancy or heart failure
- Using face masks for anticholinergics in patients at risk for glaucoma
- Failing to supervise first β-agonist dose in patients with cardiac disease
- Not considering nebulizers when inhaler technique is poor